Keywords: isis, lilly, extend, antisense, accord, california, usa-based

Isis and Lilly extend antisense R&D accord

Article | 15 August 2005

Print This

California, USA-based Isis Pharmaceuticals has extended its antisense drug discovery collaboration with US drug major Eli Lilly.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in